Global Buerger's Disease Treatment Market Growth 2025-2031
Description
The global Buerger's Disease Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Berger"s disease occurs mostly in young and middle-aged men, and most of them have a history of heavy smoking. Typical manifestations are intermittent claudication, rest pain, and migratory thrombophlebitis. The disease mainly invades the limbs, especially the medium and small arteries of the lower limbs and their accompanying veins and superficial skin veins. The affected blood vessels present non-suppurative inflammation of the whole thickness of the vessel wall, and there is thrombosis in the lumen, which is progressive. Stenosis or even complete occlusion can cause limb ischemia and pain. In severe cases, ulcers and gangrene that are not easy to heal may occur in the limbs.
United States market for Buerger's Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Buerger's Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Buerger's Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Buerger's Disease Treatment players cover FUJIFILM Holdings Corporation, General Electric, Koninklijke Philips NV, Pluristem Inc, Shimadzu Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Buerger's Disease Treatment Industry Forecast” looks at past sales and reviews total world Buerger's Disease Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Buerger's Disease Treatment sales for 2025 through 2031. With Buerger's Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Buerger's Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Buerger's Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Buerger's Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Buerger's Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Buerger's Disease Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Buerger's Disease Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Buerger's Disease Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Vasodilators
Prostaglandins
Other
Segmentation by Application:
Hospitals
Specialty Clinics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
FUJIFILM Holdings Corporation
General Electric
Koninklijke Philips NV
Pluristem Inc
Shimadzu Corporation
Siemens Healthcare GmbH
STEMPEUTICS RESEARCH PVT LTD
Toshiba Medical Corporation
Key Questions Addressed in this Report
What is the 10-year outlook for the global Buerger's Disease Treatment market?
What factors are driving Buerger's Disease Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Buerger's Disease Treatment market opportunities vary by end market size?
How does Buerger's Disease Treatment break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Berger"s disease occurs mostly in young and middle-aged men, and most of them have a history of heavy smoking. Typical manifestations are intermittent claudication, rest pain, and migratory thrombophlebitis. The disease mainly invades the limbs, especially the medium and small arteries of the lower limbs and their accompanying veins and superficial skin veins. The affected blood vessels present non-suppurative inflammation of the whole thickness of the vessel wall, and there is thrombosis in the lumen, which is progressive. Stenosis or even complete occlusion can cause limb ischemia and pain. In severe cases, ulcers and gangrene that are not easy to heal may occur in the limbs.
United States market for Buerger's Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Buerger's Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Buerger's Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Buerger's Disease Treatment players cover FUJIFILM Holdings Corporation, General Electric, Koninklijke Philips NV, Pluristem Inc, Shimadzu Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Buerger's Disease Treatment Industry Forecast” looks at past sales and reviews total world Buerger's Disease Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Buerger's Disease Treatment sales for 2025 through 2031. With Buerger's Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Buerger's Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Buerger's Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Buerger's Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Buerger's Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Buerger's Disease Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Buerger's Disease Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Buerger's Disease Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Vasodilators
Prostaglandins
Other
Segmentation by Application:
Hospitals
Specialty Clinics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
FUJIFILM Holdings Corporation
General Electric
Koninklijke Philips NV
Pluristem Inc
Shimadzu Corporation
Siemens Healthcare GmbH
STEMPEUTICS RESEARCH PVT LTD
Toshiba Medical Corporation
Key Questions Addressed in this Report
What is the 10-year outlook for the global Buerger's Disease Treatment market?
What factors are driving Buerger's Disease Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Buerger's Disease Treatment market opportunities vary by end market size?
How does Buerger's Disease Treatment break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
95 Pages
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Buerger's Disease Treatment by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Buerger's Disease Treatment by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
